Nona Biosciences
Jingsong Wang is a prominent figure in the biotechnology sector, currently serving as Chairman of Nona Biosciences since November 2022 and as Chairman of the Board of Directors and CEO of Harbour BioMed since December 2016. Wang holds a position on the Board of Directors at Frontage Holdings Corporation, where chairsts both the Remuneration and Nomination Committees. With a strong academic background, Wang served as an Adjunct Assistant Professor of Medicine and Radiology at the University of Pennsylvania School of Medicine from 2007 to 2022. Previous experiences include board roles at Silicon Therapeutics and Genzyme companies, alongside leadership positions at Sanofi, overseeing R&D activities in China. Jingsong Wang's education includes degrees from Harvard Medical School, Harvard T.H. Chan School of Public Health, and the Medical College of Georgia at Augusta University.
This person is not in any teams
This person is not in any offices
Nona Biosciences
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal immunization, single B cell screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging the advantages of Harbour Mice® platforms and the experienced therapeutic antibody discovery team. Harbour Mice® generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Integrating Harbour Mice® and a single B cell cloning platform, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs by diversified partnership strategies including co-discovery, platform and antibody discovery, and platform license. The values of the antibody discovery platforms and flexible partnership models have been well validated by more than 50 industry and academic partners within over 200 projects.